New Risk • May 16
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended March 2025. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2025 fiscal period end). Revenue has declined by 21% over the past year. Minor Risk Market cap is less than US$100m (₩141.3b market cap, or US$94.3m). New Risk • May 13
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩149.2b (US$99.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 21% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported March 2025 fiscal period end). Market cap is less than US$100m (₩149.2b market cap, or US$99.8m). Aankondiging • Mar 06
Sebitchem Co., LTD, Annual General Meeting, Mar 26, 2026 Sebitchem Co., LTD, Annual General Meeting, Mar 26, 2026, at 09:00 Tokyo Standard Time. Location: auditorium, 120-1, gongdan 3-gil, gyeongsangbuk-do, gimcheon South Korea New Risk • Mar 04
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩129.5b (US$88.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 77% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported March 2025 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩129.5b market cap, or US$88.6m). New Risk • Dec 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 77% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported March 2025 fiscal period end). New Risk • Sep 26
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩139.9b (US$99.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 77% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩139.9b market cap, or US$99.1m). New Risk • Jul 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 77% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₩112.0b market cap, or US$80.7m). New Risk • May 15
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (₩95.6b market cap, or US$68.5m). Aankondiging • Feb 22
Sebitchem Co., LTD, Annual General Meeting, Mar 17, 2025 Sebitchem Co., LTD, Annual General Meeting, Mar 17, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 120-1, gongdan 3-gil, gyeongsangbuk-do, gimcheon South Korea Aankondiging • Feb 04
Sebitchem Co., LTD announced that it expects to receive KRW 10.00000878 billion in funding Sebitchem Co., LTD announced a private placement to issue 648,509 shares at an issue price of KRW 15,420 per share for the gross proceeds of KRW 10,000,008,780 on February 3, 2025. The transaction will include participation from new investor SKIL Eco Synergy Value Up No. 1 Co., Ltd. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on March 31, 2025. Aankondiging • Nov 22
Sangol Co., Ltd. agreed to acquire 3.36% stake in Sebitchem Co., LTD (KOSDAQ:A107600) from Park Jingyu, Park Yongjae and Park Yongjin. Sangol Co., Ltd. agreed to acquire 3.36% stake in Sebitchem Co., LTD (KOSDAQ:A107600) from Park Jingyu, Park Yongjae and Park Yongjin for KRW 3.8 billion on October 18, 2024. A cash consideration of KRW 3.85 billion valued at KRW 23020 per share will be paid by Sangol Co., Ltd. As part of consideration, KRW 3.85 billion is paid towards common equity of Sebitchem Co., LTD.
Sangol Co., Ltd. completed the acquisition of 3.36% stake in Sebitchem Co., LTD (KOSDAQ:A107600) from Park Jingyu, Park Yongjae and Park Yongjin on November 20, 2024. New Risk • Aug 05
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩115.5b (US$84.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (9.2% average weekly change). Market cap is less than US$100m (₩115.5b market cap, or US$84.7m). New Risk • Jul 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Share price has been volatile over the past 3 months (7.6% average weekly change). Aankondiging • Nov 25
SebitChemCo., Ltd. announced that it expects to receive KRW 17 billion in funding SebitChemCo., Ltd. announced a private placement of Series 2 unregistered, non-guaranteed, privately placed debentures with warrants for the gross proceeds of KRW 8,500,000,000 on November 23, 2022. The transaction will include participation from Recycling No. 1 New Technology Fund. The transaction has been approved by the board of the directors of the company. The bonds are 100% convertible into 76,992 common shares at a conversion price of KRW 110,400 between the period starting from November 25, 2023 to October 25, 2027 and will mature on November 25, 2027. The transaction is expected to close on November 25, 2022. The bonds are restricted to a holding period of one year.
On the same date, the company also announced a private placement of series 1 bearer type non-interest-bearing non-guaranteed privately placed convertible bonds for gross proceeds of KRW 8,500,000,000 on November 23, 2022. The transaction will include participation from Recycling No. 1 New Technology Fund. The transaction has been approved by the board of the directors of the company. The zero coupon bonds are fully convertible into 76,992 common shares of Savit Chem Co., Ltd. at a conversion price of KRW 110,400 from November 25, 2023 and ending on October 25, 2027 and will mature on November 25, 2027. The bonds will be issued through yearning method. The expected date of payment and subscription is November 25, 2022. The bonds are restricted to a holding period of one year.